Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats

Abstract

In order to develop a successful gene therapy system for the healing of bone defects, we developed a murine leukemia virus (MLV)-based retroviral system expressing the human bone morphogenetic protein (BMP) 4 transgene with high transduction efficiency. The bone formation potential of BMP4 transduced cells was tested by embedding 2.5 × 106 transduced stromal cells in a gelatin matrix that was then placed in a critical size defect in calvariae of syngenic rats. Gelatin matrix without cells or with untransduced stromal cells were the two control groups. The defect area was completely filled with new bone in experimental rats after 4 weeks, while limited bone formation occurred in either control group. Bone mineral density (BMD) of the defect in the gene therapy group was 67.8 ± 5.7 mg/cm2 (mean ± s.d., n = 4), which was 119 ± 10% of the control BMD of bone surrounding the defect (57.2 ± 1.5 mg/cm2). In contrast, BMD of rats implanted with untransduced stromal cells was five-fold lower (13.8 ± 7.4 mg/cm2, P < 0.001). Time course studies revealed that there was a linear increase in BMD between 2–4 weeks after inoculation of the critical size defect with 2.5 × 106 implanted BMP4 cells. In conclusion, the retroviral-based BMP4 gene therapy system that we have developed has the potential for regeneration of large skeletal defects.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Wozney JM et al. Novel regulators of bone formation: molecular clones and activities Science 1988 242: 1528–1534

    Article  CAS  Google Scholar 

  2. Reddi AH . Role of morphogenetic proteins in skeletal tissue engineering and regeneration Nat Biotechnol 1998 16: 247–252

    Article  CAS  Google Scholar 

  3. Gerhart TN et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein Clin Orthop 1993 293: 317–326

    Google Scholar 

  4. Cook SD et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates J Bone Joint Surg Am 1995 77: 734–750

    Article  CAS  Google Scholar 

  5. Zegzula HD et al. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2) J Bone Joint Surg Am 1997 79: 1778–1790

    Article  CAS  Google Scholar 

  6. Sheehan JP et al. Molecular methods of enhancing lumbar spine fusion Neurosurgery 1996 39: 548–554

    CAS  PubMed  Google Scholar 

  7. Winn SR et al. Gene therapy approaches for modulating bone regeneration Adv Drug Deliv Rev 2000 42: 121–138

    Article  CAS  Google Scholar 

  8. Kirker-Head CA . Potential applications and delivery strategies for bone morphogenetic proteins Adv Drug Deliv Rev 2000 43: 65–92

    Article  CAS  Google Scholar 

  9. Baltzer AW et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene Gene Therapy 2000 7: 734–739

    Article  CAS  Google Scholar 

  10. Lieberman JR et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats J Bone Joint Surg Am 1999 81: 905–917

    Article  CAS  Google Scholar 

  11. Riew KD et al. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model Calcif Tissue Int 1998 63: 357–360

    Article  CAS  Google Scholar 

  12. Lou J et al. Effect of bone morphogenetic protein-12 gene transfer on mesenchymal progenitor cells Clin Orthop 1999 369: 333–339

    Article  Google Scholar 

  13. Alden TD et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector Hum Gene Ther 1999 10: 2245–2253

    Article  CAS  Google Scholar 

  14. Musgrave DS et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone Bone 1999 24: 541–547

    Article  CAS  Google Scholar 

  15. Moutsatsos IK et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration Mol Ther 2001 3: 449–461

    Article  CAS  Google Scholar 

  16. Gonda K et al. Heterotopic ossification of degenerating rat skeletal muscle induced by adenovirus-mediated transfer of bone morphogenetic protein-2 gene J Bone Miner Res 2000 15: 1056–1065

    Article  CAS  Google Scholar 

  17. Peng H et al. Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4 Mol Ther 2001 4: 95–104

    Article  CAS  Google Scholar 

  18. Stover ML et al. Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice Mol Ther 2001 3: 543–550

    Article  CAS  Google Scholar 

  19. Oreffo RO, Virdi AS, Triffitt JT . Retroviral marking of human bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo J Cell Physiol 2001 186: 201–209

    Article  CAS  Google Scholar 

  20. Breitbart AS et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene Ann Plast Surg 1999 42: 488–495

    Article  CAS  Google Scholar 

  21. Schmitz JP et al. Characterization of rat calvarial nonunion defects Acta Anat (Basel) 1990 138: 185–192

    Article  CAS  Google Scholar 

  22. Krebsbach PH et al. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo Hum Gene Ther 2000 11: 1201–1210

    Article  CAS  Google Scholar 

  23. Kenley R et al. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2) J Biomed Mater Res 1994 28: 1139–1147

    Article  CAS  Google Scholar 

  24. Lieberman JR et al. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents J Orthop Res 1998 16: 330–339

    Article  CAS  Google Scholar 

  25. Engstrand T et al. Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation Hum Gene Ther 2000 11: 205–211

    Article  CAS  Google Scholar 

  26. Hollinger JO, Winn SR . Tissue engineering of bone in the craniofacial complex Ann NY Acad Sci 1999 875: 379–385

    Article  CAS  Google Scholar 

  27. Sweeney TM et al. Repair of critical size rat calvarial defects using extracellular matrix protein gels J Neurosurg 1995 83: 710–715

    Article  CAS  Google Scholar 

  28. Krebsbach PH et al. Repair of craniotomy defects using bone marrow stromal cells Transplantation 1998 66: 1272–1278

    Article  CAS  Google Scholar 

  29. Wang J, Glimcher MJ . Characterization of matrix-induced osteogenesis in rat calvarial bone defects: II. Origins of bone-forming cells Calcif Tissue Int 1999 65: 486–493

    Article  CAS  Google Scholar 

  30. Hammonds RG Jr et al. Bone-inducing activity of mature BMP-2b produced from a hybrid BMP-2a/2b precursor Mol Endocrinol 1991 5: 149–155

    Article  CAS  Google Scholar 

  31. Zhang RW et al. Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma Calcif Tissue Int 1995 56: 283–291

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This material is based on work supported by a special appropriation to the Jerry L Pettis Memorial VA Medical Center, Musculoskeletal Disease Center. All work was performed with facilities provided by the Department of Veterans Affairs. We thank Dr D Strong for encouragement and helpful discussions and Dr C Nyght for establishing the Western blot procedures. We acknowledge the excellent technical assistance of Yue-hua Liu, Mitra Bhattacharyya, Cheryl Busse and Jann Smallwood.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gysin, R., Wergedal, J., Sheng, MC. et al. Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Ther 9, 991–999 (2002). https://doi.org/10.1038/sj.gt.3301772

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301772

Keywords

This article is cited by

Search

Quick links